Back

ProANP31-67 ameliorates adverse cardiac remodeling and improves systolic and diastolic functions in a preclinical model of cardiorenal syndrome

30 April 2022 (10:50 - 11:30)
Organised by: Logo
Congress Presentation Part of: Moderated poster 9 - Drugs Drugs, Drug Targets CBS PREMIUM ACCESS Frontiers in CardioVascular Biomedicine 2022 Council on Basic Cardiovascular Science

About the speaker

Photo
Professor Alessandro Cataliotti

Oslo University Hospital Rikshospitalet, Oslo (Norway)

3 More presentations in this session

Presentation thumbnail
Sex-related differential susceptibility to ponatinib-induced cardiotoxicity and its relationship to modulation of Notch signaling in a murine model
Assistant Professor R. Madonna (Pisa, IT)
Abstract
Presentation thumbnail
A common plasma lipidomics signature of cardiometabolic and coronary risk in statin users
Doctor S. Rocchiccioli (Pisa, IT)
Abstract
Presentation thumbnail
INZ-701, a recombinant ENPP1-Fc protein, effectively treats and prevents neointimal proliferation in WT and ENPP1 Deficient mice
Doctor F. Rutsch (Munster, DE)
Abstract

Access the full session

Session thumbnail
Moderated poster 9 - Drugs

The Event

Event poster

Frontiers in CardioVascular Biomedicine 2022

30 April 2022 10:50 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources